ArriVent BioPharma, Inc. Common Stock (AVBP) — Defensive Interval Ratio
ArriVent BioPharma, Inc. Common Stock (AVBP) has a Defensive Interval Ratio of 2863 days as of June 2026. Defensive assets of $218.44 Million (cash $-, short-term investments $218.44 Million, receivables $-) cover 2863 days of daily cash needs of $76.28K/day.
Defensive Interval Ratio
Defensive Assets
Daily Cash Need
Current Liabilities
ArriVent BioPharma, Inc. Common Stock Defensive Interval Ratio (2021–2025)
This chart shows how ArriVent BioPharma, Inc. Common Stock's Defensive Interval Ratio has evolved across 5 annual periods from 2021 to 2025. As of June 2026, the ratio stands at 2863 days, meaning defensive assets of $218.44 Million can fund 2863 days of operations without new revenue. For the complete balance sheet picture, see how large is ArriVent BioPharma, Inc. Common Stock's balance sheet.
Annual Defensive Interval Ratio for ArriVent BioPharma, Inc. Common Stock (2021–2025)
The table below presents the year-by-year Defensive Interval Ratio for ArriVent BioPharma, Inc. Common Stock from 2021 to 2025, covering 5 annual filings. Each row shows defensive assets, daily cash need, the DIR in days, and the change in days compared to the prior year. See ArriVent BioPharma, Inc. Common Stock working capital to net assets to evaluate short-term liquidity relative to the company's equity base.
| Year | DIR (days) | Defensive Assets (USD) | Daily Cash Need | Cash | ST Investments | Change (days) |
|---|---|---|---|---|---|---|
| 2025 | 3761 days | $267.34 Million | $71.08K/day | $- | $267.28 Million | ▲ +696 days |
| 2024 | 3065 days | $145.07 Million | $47.33K/day | $- | $144.57 Million | ▲ +3041 days |
| 2023 | 24 days | $761.00K | $31.85K/day | $- | $0.00 | ▲ +2 days |
| 2022 | 22 days | $500.00K | $22.90K/day | $- | $- | ▼ -28 days |
| 2021 | 50 days | $250.00K | $4.98K/day | $- | $- | — |